BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Deloitte
AstraZeneca
Express Scripts
Cipla
Novartis
US Army
Chubb
Covington
Merck
McKinsey

Generated: January 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020828

« Back to Dashboard

NDA 020828 describes FORTOVASE, which is a drug marketed by Hoffmann La Roche and is included in one NDA. There is one patent protecting this drug. Additional details are available on the FORTOVASE profile page.

The generic ingredient in FORTOVASE is saquinavir. There is one drug master file entry for this compound. Additional details are available on the saquinavir profile page.
Summary for 020828
Tradename:FORTOVASE
Applicant:Hoffmann La Roche
Ingredient:saquinavir
Patents:1
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 020828

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE;ORALStrength200MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Nov 7, 1997TE:RLD:Yes
Patent:➤ SubscribePatent Expiration:May 16, 2020Product Flag?Substance Flag?Delist Request?Y

Expired US Patents for NDA 020828

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Hoffmann La Roche FORTOVASE saquinavir CAPSULE;ORAL 020828-001 Nov 7, 1997 ➤ Subscribe ➤ Subscribe
Hoffmann La Roche FORTOVASE saquinavir CAPSULE;ORAL 020828-001 Nov 7, 1997 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Colorcon
Citi
Harvard Business School
Fish and Richardson
Fuji
Accenture
Federal Trade Commission
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot